In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute. THC ...

A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review ...

Is marijuana getting too high on its own promises? New research published Monday adds to the evidence that medical cannabis ...

Faced with chronic nerve pain, many people turn to cannabis-based medications, hoping for relief that conventional treatments ...

In A Nutshell A mouse study found that low-dose THC combined with celecoxib protected memory and reduced brain damage linked to Alzheimer’s. THC alone reduced toxic proteins but also increased ...

The two main compounds in cannabis are in a constant balancing act. This is an Inside Science story. (Inside Science) -- Many people who use cannabis do it for the euphoric effects caused by the main ...

A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Researchers led by Markus ...